CBT profiles of cabozantinib approved for advanced renal cell carcinomas

被引：12
|
作者：
Wang, Xiangdong [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Inst Clin Sci, Shanghai Inst Clin Bioinformat, Shanghai, Peoples R China
来源：
CELL BIOLOGY AND TOXICOLOGY | 2016年 / 32卷 / 04期
关键词：
KINASE; INHIBITORS; MEDICINE; GROWTH;
D O I：
10.1007/s10565-016-9349-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：259 / 261
页数：3
相关论文
共 50 条
  • [1] CBT profiles of cabozantinib approved for advanced renal cell carcinomas
    Xiangdong Wang
    Cell Biology and Toxicology, 2016, 32 : 259 - 261
  • [2] Cabozantinib Approved for First-Line Treatment of Advanced Renal Cell Carcinoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (02) : 96 - 96
  • [3] Efficacy of cabozantinib in advanced MiT family translocation renal cell carcinomas (TRCC).
    Thouvenin, Jonathan
    Alhalabi, Omar
    Hirsch, Laure
    Hasanov, Elshad
    Barthelemy, Philippe
    Martini, Dylan J.
    Campedel, Lucas
    Amrane, Karim
    Borchiellini, Delphine
    Chahoud, Jad
    Bakouny, Ziad
    Ravi, Praful
    Viswanathan, Srinivas Raghavan
    Bilen, Mehmet Asim
    Choueiri, Toni K.
    Tannir, Nizar M.
    Malouf, Gabriel G.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [4] Cabozantinib: A Review in Advanced Renal Cell Carcinoma
    Zaina T. Al-Salama
    Gillian M. Keating
    Drugs, 2016, 76 : 1771 - 1778
  • [5] Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR?
    Ciccarese, Chiara
    Massari, Francesco
    Tortora, Giampaolo
    EUROPEAN UROLOGY, 2016, 69 (05) : 969 - 970
  • [6] Cabozantinib: A Review in Advanced Renal Cell Carcinoma
    Al-Salama, Zaina T.
    Keating, Gillian M.
    DRUGS, 2016, 76 (18) : 1771 - 1778
  • [7] Cabozantinib approved for advanced medullary thyroid cancer
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (02) : 88 - 88
  • [8] Nivolumab plus cabozantinib for advanced renal cell carcinoma
    Benjamin, David J.
    Nolla, Kyle
    Cella, David
    FUTURE ONCOLOGY, 2022, 18 (39) : 4351 - 4359
  • [9] Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
    Thouvenin, Jonathan
    Alhalabi, Omar
    Carlo, Maria
    Carril-Ajuria, Lucia
    Hirsch, Laure
    Martinez-Chanza, Nieves
    Negrier, Sylvie
    Campedel, Luca
    Martini, Dylan
    Borchiellini, Delphine
    Chahoud, Jad
    Lodi, Massimo
    Barthelemy, Philippe
    Hasanov, Elshad
    Hahn, Andrew W.
    Gil, Thierry
    Viswanathan, Srinivas R.
    Bakouny, Ziad
    Msaouel, Pavlos
    Bilen, Mehmet Asim
    Choueiri, Toni K.
    Albiges, Laurence
    Tannir, Nizar M.
    Malouf, Gabriel G.
    ONCOLOGIST, 2022, 27 (12): : 1041 - 1047
  • [10] Nivolumab Approved for Advanced Renal Cell Carcinoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 67 - 67
12345